암 생검 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global cancer biopsy market size is expected to reach USD 80.48 Billion in 2034 from USD 37.27 Billion in 2025, growing at a CAGR of 8.93% during 2026-2034.The global cancer biopsy market is witnessing substantial growth due to the increasing prevalence of cancer and the rising importance of early disease diagnosis. Biopsy procedures are essential for confirming cancer diagnoses and determining appropriate treatment strategies. With growing awareness about cancer screening and the rising adoption of minimally invasive diagnostic procedures, healthcare providers are increasingly relying on advanced biopsy techniques to improve diagnostic accuracy and patient outcomes.

Several factors are driving the growth of this market, including advancements in imaging technologies, the development of liquid biopsy techniques, and increasing investments in oncology research. Liquid biopsy, in particular, has gained attention as it allows the detection of cancer biomarkers through blood samples, reducing the need for invasive procedures. Additionally, the growing adoption of precision medicine and personalized cancer treatment approaches is increasing the demand for reliable biopsy diagnostics.

The future of the cancer biopsy market looks promising as technological innovations continue to transform cancer diagnostics. Emerging diagnostic technologies, integration of artificial intelligence in pathology, and improved biomarker detection methods are expected to enhance diagnostic capabilities. With increasing healthcare expenditure and government initiatives promoting early cancer detection programs, the market is expected to experience significant growth in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Platforms & Instruments
• Kits & Reagents
• Services

By Type

• Tissue Biopsies
• Liquid Biopsies
• Others

By Application

• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Lung Cancer
• Prostate Cancer
• Skin Cancer
• Blood Cancer
• Kidney Cancer
• Liver Cancer
• Pancreatic Cancer
• Ovarian Cancer
• Others

COMPANIES PROFILED

• QIAGEN N.V., Illumina, Inc., ANGLE plc, Becton, Dickinson and Company, Myriad Genetics, Inc., Hologic, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lucence Health Inc., GRAIL, Inc., Guardant Health, Inc., Exact Sciences Corporation, Freenome Holdings, Inc., Biodesix, Inc., Oncimmune Holdings plc, Epigenomics AG, Natera, Inc., Personalis, Inc., HelioHealth

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CANCER BIOPSY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Platforms & Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CANCER BIOPSY MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Tissue Biopsies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Liquid Biopsies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CANCER BIOPSY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cervical Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Skin Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Blood Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Kidney Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.10. Liver Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.11. Pancreatic Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.12. Ovarian Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.13. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CANCER BIOPSY MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Type
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Type
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Type
  • 7.4.3 By Application
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Type
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Type
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CANCER BIOPSY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 QIAGEN N.V
  • 9.2.2 IlluminaInc
  • 9.2.3 ANGLE Plc
  • 9.2.4 Becton, Dickinson And Company
  • 9.2.5 Myriad GeneticsInc
  • 9.2.6 HologicInc
  • 9.2.7 Thermo Fisher Scientific Inc
  • 9.2.8 Danaher Corporation
  • 9.2.9 F. Hoffmann-La Roche Ltd
  • 9.2.10 Lucence Health Inc
  • 9.2.11 GRAILInc
  • 9.2.12 Guardant HealthInc
  • 9.2.13 Exact Sciences Corporation
  • 9.2.14 Freenome HoldingsInc
  • 9.2.15 BiodesixInc
  • 9.2.16 Oncimmune Holdings Plc
  • 9.2.17 Epigenomics AG
  • 9.2.18 NateraInc
  • 9.2.19 PersonalisInc
  • 9.2.20 HelioHealth